Condition: Post-Acute COVID-19 Syndrome · Sponsor: Hospices Civils de Lyon
The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.
This description comes directly from the study's public registry record.
Sébastien Couraud, Pr · 04 78 86 44 01 · Sebastien.couraud@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| Service Pneumologie aigue spécialisée et cancérologie thoracique | Pierre-Bénite, France | Recruiting |
| Hôpital Henry Gabrielle-HCL | Saint-Genis-Laval, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07356570